Skip to main content
. 2017 Jan 10;2017:8267863. doi: 10.1155/2017/8267863

Figure 4.

Figure 4

Knockdown of MIR4697HG inhibits tumor growth in vivo. (a) A xenograft model of ovarian cancer was established using SKOV3 cells with (shRNA group) or without (NC group) MIR4697HG depletion. Tumor size was periodically monitored. (b) Tumors were dissected from each mouse and shown for each group. (c) Dissected tumors were weighed for each group. It was shown that the average tumor weight was significantly less in the shRNA group, accounting for only 71% of that in the control group. p < 0.05; ∗∗p < 0.01.